2m 2m 2m 2m 2m 2m 2m
TAYSHA GENE THER (TSHA)
NASDAQ
$5.81-$0.05 (-0.90%)
Price as of Aug 03, 2026 10:20 AM EDT- $1.7BMarket Cap
- 122.81%1-Year Change
- BiotechnologyIndustry
TAYSHA GENE THER (TSHA)
$5.81-$0.05 (-0.90%)
TSHA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $5.86 | ||
Change | -$0.01 (-0.26%) | ||
Open | $5.88 | ||
High | $5.92 | ||
Low | $5.72 | ||
Previous Close | $5.88 | ||
Volume | 2,287,917 | ||
30-Day Average Volume | 2,920,147 | ||
1-Week Change | 6.16% | ||
1-Month Change | -13.95% | ||
1-Year Change | 122.81% | ||
3-Year Change | 770.47% | ||
5-Year Change | -66.11% | ||
Fundamentals | |||
Shares Outstanding | 287.4M | ||
Total Assets | $300.4M | ||
Market Cap | $1.7B | ||
Enterprise Value | $1.5B | ||
Period: QTR TTM FY | |||
Revenue | $0.00 | ||
Net Income | -$42.4M | ||
Free Cash Flow | -$40.9M | ||
EBIT | -$42.4M | ||
EBITDA | -$42.1M | ||
Net Working Capital | $262.2M | ||
EPS | -$0.12 | ||
Enterprise Value/EBITDA | -35 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 8 | ||
P/E | -49 | ||
PEG | 1 | ||
Price/Free Cash Flow | -41 | ||
Price/Operating Cash Flow | -41 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue